Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

• Satoshi Motoya,

  Roles Conceptualization, Investigation, Writing – original draft, Writing – review & editing

  Affiliation IBD Center, Hokkaido Prefectural Welfare Federation of Agricultural Cooperative, Sapporo-Kosei General Hospital, Sapporo, Japan

  ⨯
• Kenji Watanabe,

  Roles Conceptualization, Investigation, Writing – review & editing

  Affiliation Department of Intestinal Inflammation Research, Hyogo College of Medicine, Hyogo, Japan

  ⨯
• Haruhiko Ogata,

  Roles Conceptualization, Investigation, Writing – review & editing

  Affiliation Endoscopic Center, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Takanori Kanai,

  Roles Conceptualization, Investigation, Supervision, Writing – review & editing

  Affiliation Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

  ⨯
• Toshiyuki Matsui,

  Roles Conceptualization, Investigation, Writing – review & editing

  Affiliation Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan

  ⨯
• Yasuo Suzuki,

  Roles Conceptualization, Investigation, Writing – review & editing

  Affiliation Department of Internal Medicine, Toho University Medical Center Sakura Hospital, Chiba, Japan

  ⨯
• Mitsuhiro Shikamura,

  Roles Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Takeda Development Center Japan, Takeda Pharmaceutical Company, Osaka, Japan

  ⨯
• Kenkichi Sugiura,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Takeda Development Center Japan, Takeda Pharmaceutical Company, Osaka, Japan

  ⨯
• Kazunori Oda,

  Roles Conceptualization, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Regenerative Medicine Unit, Takeda Pharmaceutical Company, Kanagawa, Japan

  ⨯
• Tetsuharu Hori,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Takeda Development Center Japan, Takeda Pharmaceutical Company, Osaka, Japan

  ⨯
• Takahiro Araki,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Takeda Development Center Japan, Takeda Pharmaceutical Company, Osaka, Japan

  ⨯
• Mamoru Watanabe,

  Roles Conceptualization, Investigation, Supervision, Writing – review & editing

  Affiliation Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
• Toshifumi Hibi

  Roles Conceptualization, Investigation, Supervision, Writing – review & editing

  * E-mail: thibi@insti.kitasato-u.ac.jp

  Affiliation Center for Advanced Inflammatory Bowel Disease Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan

  http://orcid.org/0000-0002-6256-1204

  ⨯